SCHEMBL29083946

SCHEMBL29083946

COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(Br)c(Nc2cccc3c2C(=O)N(C)C3)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.63
▸ BTK Q06187 2/20 0.48
▸ INSR P06213 4/20 0.48
▸ IGF1R P08069 4/20 0.48
▸ ALK Q9UM73 4/20 0.48
▸ PLK1 P53350 2/20 0.46
▸ MAPK7 Q13164 2/20 0.46
▸ LRRK2 Q5S007 2/20 0.46
▸ BMPR1B O00238 1/20 0.45
▸ PLK4 O00444 1/20 0.45
▸ STK25 O00506 1/20 0.45
▸ RIOK3 O14730 1/20 0.45
▸ CHEK1 O14757 1/20 0.45
▸ CASK O14936 1/20 0.45
▸ AURKA O14965 1/20 0.45
▸ GAK O14976 1/20 0.45
▸ DCLK1 O15075 1/20 0.45
▸ MUSK O15146 1/20 0.45
▸ EPHB6 O15197 1/20 0.45
▸ PDPK1 O15530 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29084089 0.89 EGFR (0.64) EGFRBTKINSRIGF1RALK
SCHEMBL29084096 0.88 EGFR (0.71) EGFRBTKINSRIGF1RALK
SCHEMBL29083961 0.88 EGFR (0.65) EGFRINSRIGF1RALK
SCHEMBL27091519 0.86 EGFR (0.67) EGFRBTKINSRIGF1RALK
SCHEMBL29974578 0.85 EGFR (0.62) EGFRBTKCHEK1AURKAJAK2
SCHEMBL29084045 0.85 EGFR (0.67) EGFRBTKINSRIGF1RALK
SCHEMBL29084143 0.85 EGFR (0.57) EGFRINSRIGF1RALK
SCHEMBL29974671 0.85 EGFR (0.57) EGFRINSRIGF1RALK
SCHEMBL29083940 0.85 EGFR (0.61) EGFRBTKINSRIGF1RALK
SCHEMBL29084036 0.84 EGFR (0.65) EGFRBTKINSRIGF1RALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 — — CN claimed
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO claimed
CN-116670127-A EGFR inhibitors and compositions and uses thereof 贝达药业股份有限公司 2023-08-29 — — CN disclosed
WO-2022206797-A1 EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2022-10-06 — — WO disclosed
Send feedback